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Abstract
Prospective cohort studies have provided evidence on longer-term mortality risks of fine
particulate matter (PM2.5), but due to their complexity and costs, only a few have been
conducted.

By linking monitoring data to the U.S. Medicare system by county of residence, we
developed a retrospective cohort study, the Medicare Air Pollution Cohort Study
(MCAPS), comprising over 20 million enrollees in the 250 largest counties during 20002002. We estimated log-linear regression models having as outcome the age-specific
mortality rate for each county and as the main predictor, the average PM2.5 level for the
study period 2000. Area-level covariates were used to adjust for socio-economic status
and smoking. We reported results under several degrees of adjustment for spatial
confounding and with stratification into by eastern, central and western counties.

We estimated that a 10 µg/m3 increase in PM2.5 is associated with a 7.6% increase in
mortality (95% CI: 4.4 to 10.8%). We found a stronger association in the eastern
counties than nationally, with no evidence of an association in western counties. When
adjusted for spatial confounding, the estimated log-relative risks drop by 50%. We
demonstrated the feasibility of using Medicare data to establish cohorts for follow-up for
effects of air pollution.
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Particulate matter (PM) air pollution is a global public health problem (1). In developing
countries, levels of airborne particles still reach concentrations at which serious health
consequences are well-documented; in developed countries, recent epidemiologic
evidence shows continued adverse effects, even though particle levels have declined in
the last two decades (2-6). Increased mortality associated with higher levels of PM air
pollution has been of particular concern, giving an imperative for stronger protective
regulations (7).

Evidence on PM and health comes from studies of acute and chronic adverse effects
(6). The London Fog of 1952 provides dramatic evidence of the unacceptable shortterm risk of extremely high levels of PM air pollution (8-10); multi-site time-series studies
of daily mortality show that far lower levels of particles are still associated with shortterm risk (5)(11-13). Cohort studies provide complementary evidence on the longerterm risks of PM air pollution, indicating the extent to which exposure reduces life
expectancy. The design of these studies involves follow-up of cohorts for mortality over
periods of years to decades and an assessment of mortality risk in association with
estimated long-term exposure to air pollution (2-4;14-17). Because of the complexity
and costs of such studies, only a small number have been conducted. The most
rigorously executed, including the Harvard Six Cities Study and the American Cancer
Society’s (ACS) Cancer Prevention Study II, have provided generally consistent
evidence for an association of long-term exposure to particulate matter air pollution with
increased all-cause and cardio-respiratory mortality (2,4,14,15). Results from these
studies have been used in risk assessments conducted for setting the U.S. National
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Ambient Air Quality Standard (NAAQS) for PM and for estimating the global burden of
disease attributable to air pollution (18,19).

Additional prospective cohort studies are necessary, however, to confirm associations
between long-term exposure to PM and mortality, to broaden the populations studied,
and to refine estimates by regions across which particle composition varies. Toward this
end, we have used data from the U.S. Medicare system, which covers nearly all
persons 65 years of age and older in the United States. We linked Medicare mortality
data to PM2.5 (particulate matter less than 2.5 µm in aerodynamic diameter) air pollution
monitoring data to create a new retrospective cohort study, the Medicare Air Pollution
Cohort Study (MCAPS), consisting of 20 million persons from 250 counties and
representing about 50% of the US population of elderly living in urban settings. In this
paper, we report on the relationship between longer-term exposure to PM2.5 and
mortality risk over the period 2000 to 2002 in the MCAPS.

Materials and Methods
MCAPS is a retrospective cohort study of participants 65 years and older
enrolled in the U.S. Medicare system during the three-year period 2000-2002. To create
the cohort, we used the Medicare enrollment file for the study period, which provides a
listing of all enrollees, along with demographic information (age, race, and gender) and
county of residence.

We obtained the date of death from the Center for Medicare and Medicaid Services
(CMS); it is provided to CMS by the Social Security Agency. To validate the mortality
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data, we compared annual age- and gender-adjusted mortality rates from CMS with the
corresponding rates calculated from National Center of Health Statistics (NCHS) data.
Figure 1 displays a scatter-plot of age-gender adjusted all-cause mortality rates (log
scale) from MCAPS and NCHS data for the 250 cities for the year 2000. The correlation
coefficient is 0.998 on the original scale and 0.986 on the log scale, indicating a high
level of agreement between the two sources of mortality data for the one-year period.

For this paper, the outcome measure considered is the three-year (2000-2002) county
mortality rate for each age stratum (65-74, 75-84, and 85 years and older). Initial
analyses were also stratified by gender, but the estimated effects for men and women
were very similar: consequently, the reported analyses are not stratified by gender.

The PM2.5 data for the 250 largest U.S. counties with the most complete data were
obtained from the U.S. EPA AirData database (http://www.epa.gov/oar/data/), which
included more than 1,000 monitors for the period 2000-2002. Mean annual PM2.5
values were compiled for 2000-2002 for every county with more than 10 months of data
per year; months with four or more observations were considered to have sufficient
data. Because of little variation in PM2.5 annual averages within a county across the
three years, we used the average county PM2.5 for 2000-2002 as the chronic exposure
estimate. As 1999 was the initial year of the EPA monitoring program and coverage was
limited, 1999 data were omitted.
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We estimated the region-specific relative risks of chronic PM 2.5 exposure for the
eastern half of the U.S. with 167 urban locations (eastern U.S.), the mid-section with 51
counties (central U.S.), and the western U.S. with 32 counties extending from
Washington State to southern California (Figure 2). We conducted the analyses for all
250 counties and separately within each geographical region.

In estimating the effect on mortality of PM or other air pollutants, cohort studies have
accounted for potential confounding by 1) individual-level lifestyle factors, such as age,
gender, smoking and 2) area-level characteristics such as socio-economic factors
(SES). The MCAPS provides individual-level age, gender, and race data but not
variables on lifestyle factors. To account for SES at the county level, variables from the
2000 US Census were used. After preliminary analysis of the full suite of available
indicators, we selected two education variables -- percentage of the population with a
high school diploma and the percentage with a higher education degree (associate or
above) -- and two household income measures -- percentage of households living
below the poverty level and median household income --, as well as percent
unemployed. Area-level differences in cigarette smoking could potentially confound the
PM2.5 mortality association, although previous cohort studies found little effect in
adjusting for self-reported smoking status (20). As the MCAPS database does not have
individual- or county-level smoking information, we used mortality from chronic
obstructive pulmonary disease (COPD) as a surrogate for past smoking, since most
deaths from COPD in the United States result from smoking (21). We used data from
the NCHS to calculate the standardized mortality ratio (SMR) for COPD for the period
1993-2002, adjusted for age, race, and gender. We then included the COPD SMR in the
6
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regression model as a surrogate indicator of the long-term smoking pattern of county
residents.

We investigated potential confounding by unmeasured factors that vary smoothly across
locations. To account for these difficult-to-measure factors, we included in the
regression model a smooth function s(ui, λ) of county location ui (longitude and latitude)
with degrees of freedom λ . Smaller λ corresponds to a rougher s(ui , λ) and less
control for spatial confounding, while larger λ corresponds to a smoother s(ui , λ) and
more control for spatial confounding; λ = 0, corresponds to no adjustment for spatial
confounding.

In summary, within each age stratum, we estimated the following generalized additive
model (GAM) (22) :

logE[Yi ]=logNi + β0 + βPMPMi + βZ Zi +s(ui,λ).
Here β PM is the log relative risk of mortality associated with a one µg/m3 difference in
average PM2.5 comparing counties that are otherwise similar with respect to SES and
COPD SMR and a smooth function of location. We report results by age stratum and
with aggregation across strata. To obtain the aggregated value, we fit a single log-linear
regression with a common PM effect across the strata by allowing the adjustment for Z i
and for the smooth function to be done separately for each stratum.
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We estimated the log-relative risk β PM as we varied λ . As λ  increased, control for
spatial confounding increased and mortality was contrasted in cities with higher and
lower PM2.5 concentrations that are nearer to each other in space.

We smoothed in two dimensions in the eastern U.S. and the central U.S., and with one
dimension, latitude, in the western region. If there are no important spatial confounders
and minimal measurement error, then the PM coefficient will not change with λ . We
estimated the PM effect with λ = 0 using all 250 cities and compared our findings with
those previously published for three different levels of covariate adjustment: age-gender
only, SES covariates, and COPD SMR. All analyses were carried out with the
statistical programs R (http://www.r-project.org/) and SAS
(http://www.sas.com/technologies/analytics/statistics).

Results
Table 1 presents the total number of counties, the study population, person-years of
follow-up, the number of deaths, and the crude death rates for the eastern, central, and
western U.S. The study population and the numbers of deaths exceed 20 million and
2.5 million, respectively. The study includes more than 50 million person-years of followup between 2000 and 2002.

The MCAPS data provide strong evidence that mortality is higher in counties with higher

PM2.5 when there is no adjustment for potential confounding by unmeasured spatial
variables ( λ = 0). Table 2 summarizes the estimated log relative risk of death associated
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with a 10 µg/m3 increase in PM2.5 level obtained using all 250 and setting λ = 0. We
estimate that a county with 10 µg/m3 per cubic meter higher long-term average PM2.5
has 7.6 percent higher (95% CI: 4.4 to 10.8% higher) mortality than a county with
comparable age and gender distribution. Control for SES indicators and COPD SMR
results in little change in the estimates. The analyses were done using Medicare and
NCHS mortality rates and results were qualitatively similar.

Table 3 presents the estimated log relative risks of death separately for the eastern
U.S., the central U.S., and the western U.S. without controlling for spatial confounding
( λ = 0), and for the three levels of adjustment for area-level measured covariates. For
the 167 eastern U.S. counties and the 52 central US counties, we found that the logrelative risks estimates were higher than the national estimate. Estimates are smaller
but still statistically significant with adjustment for SES and COPD. For the 32 western
counties, we found little evidence for an association of PM2.5 with mortality.

Table 4 summarizes separately for the three geographical regions the percent of PM
variation remaining for estimation of the log relative risk for several values of the
smoothing parameter λ . Even for the largest values of λ considered, at least 15% of
the variation in PM remains to estimate the log-relative risk.
Figures 2, 3, and 4 show by region the estimated PM log relative risks after controlling
for age, gender, SES indicators, and COPD SMR for a range of values of λ . For the
eastern U.S. (Figure 2), the estimated log-relative risks become progressively smaller
as λ increases; an increase in λ removes more of the spatially smooth variation in PM
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2.5 from this predictor, and thus protects against spatial confounders that also vary
smoothly. Figures A1 and A2 (see supplemental material) show overlapping hills of
mortality and PM2.5 in the eastern U.S. These coincident hills are the major source of
the positive association estimated by the log-linear model with λ ≤ 8. Setting this smooth
variation aside and considering instead the variation at more local spatial scales, the
PM effect on mortality is roughly half as large; however, it remains statistically
significant until λ ≥ 40 . For the central U.S. (Figure 3), the estimated log-relative risk
also diminishes as λ increases and loses statistical significance for λ ≥ 18. Finally, for
the 32 western U.S. locations (Figure 4), there is little evidence of an association
between chronic PM 2.5 and mortality for any of the three age strata and for any value
of λ . The annual average PM2.5 levels vary among the western counties with a standard
deviation of 4.6 µg/m3, nearly twice as great as observed in the eastern U.S. Annual
mortality rates also vary substantially, but air pollution levels and mortality rates,
aggregated to the county level, are not correlated for the 32 western locations.

Discussion
This paper presents results from the Medicare Cohort Air Pollution Study (MCAPS), the
largest cohort study of air pollution effects on morbidity and mortality to date, with 2.5
million deaths during more than 50 million person-years of follow-up. In comparison,
the ACS Study (20) had 20,765 deaths in the sub-cohort used in the analyses of air
pollution and mortality. Given the availability of 250 locations, we have stratified the
analyses geographically, choosing strata that broadly reflected differing source mixes
and background disease patterns. This stratification also controls for potential
confounders that vary on broad geographic scales.
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The MCAPS basic analysis ( λ = 0 ) gives results similar to those previously published
from the Six Cities (14) and the ACS (2) studies. The relative risk estimate is 15.4% per
10 µg/m3 increase in PM2.5 (95% CI: 10.2 to 20.6%) for the youngest age group in
MCAPS, compared to the Six Cities and ACS studies values of 15.3 and 12.4 %,
respectively. While the MCAPS data lack individual-level risk factor information, the
MCAPS results changed little with inclusion of county-level SES indicators and the
COPD SMR in the log-linear regression model (Table 3).
In MCAPS, we found evidence for effect modification by age - a drop in relative risk with
increasing age (Table 2) - and by geographic location. This decline may reflect the
many competing causes of death for which the hazard of death increases with age. If
the hazard is increased for only a subset of the competing causes by PM2.5, then the
relative risk will drop with increasing age.

There was a strong pattern of effect modification by geographic location with evidence
for the positive association between PM2.5 and mortality coming entirely from the central
and eastern United States. The positive PM-mortality association estimated from the
176 counties in the eastern U.S. could be caused by the overlapping hills of mortality
and PM2.5 that peak near the Ohio River Valley. The elevated relative risk estimates in
the central region are substantially determined from comparisons of Texas counties,
where PM2.5 concentrations and mortality rates are higher, to more northern counties
where both are relatively lower.
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No positive association was found between county-level PM2.5 concentration and
mortality rates for the 32 urban counties in the western U.S. In the MCAPS cohort, the
lack of association for the West is largely because the Los Angeles area counties have
higher PM2.5 levels than other western counties, but not higher adjusted mortality rates.

Several previous studies have addressed PM exposure and mortality in California,
based on gradients of exposure within the state. Abbey et al. (23) reported a follow-up
of the Adventist Health Study, a cohort study of more than 6,000 nonsmoking residents
of three air basins: San Francisco, Los Angeles, and San Diego. They found a nonsignificant increase in all-cause mortality of roughly 5% per 10 μg/m3 increase in PM10 in
males and no effect in females. They also reported a statistically significant association
in respiratory deaths with fraction of days above 100 μg/m3 of PM10 for both genders.
Enstrom (24) tracked mortality from 1973 through 2002 in 50,000 California participants
in the first national cohort study carried out by the ACS. Using PM2.5 data for 11
counties in 1979-1983, he found no association across the full follow-up period and
evidence of a small effect during the first decade of follow-up. Misclassification arising
from the limited exposure data available may have biased this study towards the null.
Most recently, Jerrett et al. (3) investigated the PM-mortality association in a subset of
the second ACS cohort living in Los Angeles. They estimated an 11% increase in
mortality per 10 μg/m3 of PM2.5 (95% CI: -1 to 25%), using an indicator of chronic PM
exposure based on a model that incorporated measured PM, traffic patterns, and
residential proximity to freeways. The many methodological differences between the
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MCAPS cohort and the other three cohorts providing findings for California residents
prevent any reconciliation of the differing findings.

By increasing the degrees of freedom λ for the nuisance spatial function, we examined
the change in relative risk estimates, as greater weight is given to the comparison of
counties closer to one another. Absent confounding by unmeasured variables and any
effect on measurement error, the PM2.5 relative risk of death should be similar
regardless of the value of λ . That is, on the assumption that PM2.5 exposure causes
death, the evidence for association should exist when comparing distant locations ( λ
smaller) or neighboring locations ( λ greater).

Using this analytic approach, we find that the relative risk estimates for the eastern and
central U.S. counties decrease by roughly 50% when more distant city comparisons are
down-weighted in the analysis. Nevertheless, both positive and statistically significant
associations remain for a wide range of smoothing parameters. There are competing
explanations for the finding that the relative risks estimates decrease as λ is increased.
Confounding by unobserved variables is one possibility. Assuming that the hill in
mortality in the east is caused by PM2.5 (Figures A1 and A2, see supplemental material),
the reduced association at smaller spatial scales may reflect unmeasured confounders
that vary locally, but not regionally. If the PM-mortality association is not causal, the
mortality hill might be caused by factors other than PM2.5 that co-vary smoothly in space
as PM2.5.
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These potential confounders include “ecologic” effects that result from using aggregate
rather than individual exposure and risk factor data. As detailed in Appendix A, the
observed mortality rate for a county may be a biased estimate of the true rate because
only county-level exposure and covariate data and not individual-level data are
available. The appendix decomposes the bias into five terms, coming from: 1)
differences between the baseline-risk-weighted personal PM2.5 exposure (x) and the
aggregated values used in our models; 2) differences between the baseline-riskweighted averages of personal characteristics (e.g., smoking and SES) (z) and their
aggregated values used in our models; 3-4) baseline-risk-weighted variance within
counties in PM2.5 exposure (x) and personal characteristics (z); and 5) covariance within
counties in the personal PM2.5 exposure and personal characteristics. If the countyspecific bias comprising these five terms varies across counties with PM2.5 exposure,
then the relative risk estimates will be biased.

Within the data reported here, we cannot evaluate the potential for ecologic bias from
these terms. However, Krewski et al. (20) have compared relative risk estimates from
both the American Cancer Society and Six Cities studies with and without control for
individual-level characteristics including smoking, exercise, education, and occupational
exposures. They found little change in the PM relative risk estimates, suggesting that
terms 2, 4, and 5 are negligible for those personal characteristics measured in these
two studies.
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Terms 1 and 3 are the effects of using ambient rather than personal level exposure data
as in most previous cohort studies of chronic air pollution exposure. While there is likely
some difference between average personal PM2.5 exposure and the average ambient
values used in this, and all other cohort studies, we do not anticipate that this difference
co-varies with PM2.5 levels across the country, a spatial pattern of variation that would
be necessary to produce bias in relative risk estimates. In its classification of exposure,
the MCAPS design is comparable to both the Six Cities and ACS studies, which also
assigned exposures based on centrally-sited monitors. In some other cohort studies,
exposures were been estimated at the individual level using models and residence
location (3,17). This approach can assign estimates to most or even all study
participants, potentially reducing the effects of exposure measurement error.

An alternate explanation for the dependence of the relative risk estimate on λ is that
PM2.5 is not the causal factor but a surrogate for one of its constituents or for another
pollutant. If the actual toxic exposure is a component of PM2.5 that varies smoothly and
is highly correlated with PM2.5 at larger spatial scales, but has little or no local variation,
then the local PM2.5 variation would not be associated with mortality. Our results point
toward a component for which PM2.5 is a better surrogate on larger spatial scales than
on more local scales.

A strength of these and some other cohort studies is their use of mortality rates that are
adjusted not only for age, gender, and race, but also for personal characteristics that
might confound the PM-mortality association. However, in the American Cancer Society
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Study, when the sensitivity of pollution relative rates to potential confounding variables
was studied in detail (20), little evidence of confounding by individual-level information
was observed, once age, gender, and race were account for. The analyses in these
studies have not included a smooth spatial term, so that the approach is equivalent to
setting λ = 0 in our model formulation. Krewski et al. (20) and Burnett et al. (25) have
previously accounted for spatial autocorrelation in estimating chronic effects of PM2.5
and PM10 by including a loess smoother in the model. They used a frailty extension of
the Cox proportional hazards model which assumes the existence of a latent spatial
process that explains the correlation among deaths rates from neighboring regions.
However, they assume that the latent process is orthogonal to the spatial field of PM2.5
concentrations, allowing PM2.5 to explain as much as possible of the mortality spatial
pattern and then using a latent process to represent residual spatial autocorrelation. In
our approach, we assume that the latent spatial process is a fixed effect that may not be
orthogonal to the PM2.5 field. We remove the spatial variation that can be captured by a
smooth function (e.g., loess or spline) with the chosen degrees of freedom and then
estimate the association of mortality with the remaining variation in PM2.5.
In spite of these methodological complexities, we have shown that a cohort can be
established using Medicare participants and routine monitoring data for investigating air
pollution and mortality on longer-term time frames. In our initial analyses of the MCAPS
data, we confirmed the association between PM2.5 and mortality found in other studies
but find substantial and unexplained geographic heterogeneity in the effect of PM2.5
across the United States.
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Figure Legends
Figure A1: Scatter-plot of Medicare versus NCHS age-gender adjusted all-cause
mortality rates (log scale) for the 250 cities for the year 2000.

Figure A2: Smoothed PM2.5 surface using GAM with a two dimensional loess smoother
of latitude and longitude employing 12 degrees of freedom while controlling for
proportion with high-school education, proportion with degree, proportion living in
poverty, proportion unemployed, median income, and the standardized mortality ratio
for COPD. PM2.5 residuals are plotted on the pollution surface, red indicating where the
actual PM2.5 is above the predicted surface and green when below.

Figure 1: Smoothed mortality surface using GAM with a two dimensional loess
smoother of latitude and longitude employing 12 degrees of freedom while controlling
for proportion with high-school education, proportion with degree, proportion living in
poverty, proportion unemployed, median income, and the standardized mortality ratio
for COPD. Standardized mortality ratios (100 * actual mortality/predicted mortality) are
shown. The color red is used to indicate when the number of deaths exceeds the
predicted number of deaths and the color green when the predicted number of deaths
exceeds the number of deaths at a location.
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Figure 2: Point estimates and 95% confidence intervals of the mortality log-relative
risks associated with average exposure to PM2.5 over the period 2000-2002 for different
values of the smoothing parameter λ for the 167 counties located in the eastern U.S.

Figure 3: Point estimates and 95% confidence intervals of the mortality log-relative risks
associated with average exposure to PM2.5 over the period 2000-2002 for different
values of the smoothing parameter λ for the 51 counties located in the central U.S.

Figure 4: Point estimates and 95% confidence intervals of the mortality log-relative risks
associated with average exposure to PM2.5 over the period 2000-2002 for different
values of the smoothing parameter λ for the 32 counties located in the western U.S.

Table 1. Number of counties, person-years of follow-up, deaths and crude death rates stratified by region
for the MCAPS data; US Medicare population (as described), 2000-2002.
Eastern U.S.

Central U.S.

Western U.S.

Total
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Number of counties

167

51

32

250

Persons (millions)

13.1

3.6

3.7

20.3

Person-years (millions)

33.5

8.9

9.5

51.9

Deaths (millions)

1.76

0.46

0.46

2.68

52.5

51.7

48.8

51.7

Crude rate (deaths/1,000
person years)

19
Hosted by The Berkeley Electronic Press

Table 2. Percent increase and 95% confidence interval in mortality per 10 µg/m3 PM2.5 estimated from the
log-linear regression using all 250 counties with no spatial adjustment ( λ = 0 ) for MCAPS data for three
levels of adjustment for demographic and socioeconomic variables; US Medicare population (as
described), for the period 2000-2002..

Ages

All

65-74

75-84

85+

Adjustment
% Inc

95% CI

% Inc

95% CI

% Inc

95% CI

% Inc

95% CI

Age

7.7

5.4,10.0

15.6

11.7, 19.6

8.1

4.2, 12.1

-0.5

4.4, 3.5

Age+SES

8.6

6.8,10.4

14.5

11.4, 17.6

9.1

6.0, 12.1

2.3

0.7, 5.4

Age+SES+COPD

7.7

6.2, 9.3

12.2

9.5, 14.8

8.6

6.0, 11.2

2.6

0.0, 5.2
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Table 3. Percent increase and 95% confidence interval in mortality per 10 µg/m3 PM2.5 estimated from
the log-linear regression separately for the 167 counties in the eastern U.S, the 51 counties in the central
U.S. and the 32 counties in the western U.S. (32) with no spatial adjustment ( λ = 0 ) for MCAPS data for
three levels of adjustment for demographic and socioeconomic variables; for the period 2000-2002..

Central U.S.

Western U.S.

(n=51)

(n=32)

Eastern U.S. (n=167)

All

% Inc

95% CI

% Inc

95% CI

% Inc

95% CI

% Inc

95% CI

Age

7.7

5.4,10.0

12.5

9.1,15.9

19.6

11.5, 27.7

2.9

-0.6 ,6.4

Age+SES

8.6

6.8,10.4

10.6

8.0,13.2

16.8

10.3, 23.2

0.6

-3.4, 4.6

Age+SES+COPD

7.7

6.2, 9.3

5.9

4.0, 7.7

17.8

11.9, 23.7

-2.5

-6.2, 1.1
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Table 4. Residual variance and percent of total for mean PM2.5 (2000-2002) as a function of degrees of
freedom () in loess smoother; US Medicare population (as described), for the period 2000-2002..

Eastern U.S.

Central U.S.

Western U.S.

df ( λ )

0

3.0

8.0

15.0

20.3

35.2

Variance

4.98

2.59

1.37

1.13

1.05

0.78

% Variance

100

52.1

27.6

22.8

21.1

15.7

0

3.3

8.0

10.2

15.0

20.9

Variance

3.67

2.06

1.29

1.20

0.90

0.61

% Variance

100

56.1

35.2

32.7

24.6

16.5

0

1.0

2.0

4.0

5.9

10.2

Variance

20.8

11.09

8.90

6.98

5.94

4.05

% Variance

100

53.3

42.8

33.6

28.6

19.5

df ( λ )

df ( λ )
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Appendix A

This appendix derives expressions for the expected rate μc of mortality for county c from
a relative risk model for the risk of death λci for person I in county c. Let xci and zci be
the long-term average personal exposure and a set of personal characteristics (e.g.,
smoking, exercise level, occupational exposures, and SES) for person i. Let xc be the
measured ambient PM2.5 exposure and let zc be the county average of the personal
characteristics,

z c = 1/ n c ∑ z ci .

Finally, let uc be unmeasured county characteristics such as

i

availability of health services, local cultural beliefs and other factors that might confound
the PM2.5 –mortality association.

The individual level risk model can be written

λci = λ0ci exp{β x x ci + β z zci + β u uc }
λci = λ0ci exp{β x (x ci − x c + x c ) + β z (z ci − zc + zc ) + β u uc }
Let yci =1 if person I from county c dies during mci years of follow-up and define yc = ∑ yci
i

to be the number of deaths in the county with Mc total years of follow-up.

Then the expected number of deaths in county c is given by

μc = E(y c ) = ∑ mci λci = ∑ mci λ0ci exp{β x x ci + β z zci + β u uc }
i

i

μc = exp{β x x c + β z zc + β u uc } × bc
where bc is the potential “bias-causing” factors that results from using aggregated rather
than individual-level exposure and personal-characteristic data.
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The bias term can be approximated by

bc = ∑ mciλ0ci exp{βx xci − xc ) + βz (zci − zc )}
i

bc ≈ βx (xcw − xc ) + βz (zcw − zc ) +

βx2
2

Varcw (x) +

βz2
2

Varcw (z) + Covcw (x,z).

Here x cw and z cw are the cumulative baseline risk weighted mean PM exposure and
mean personal characteristics for county c; Varcw (x) and Varcw (z) are the cumulative
baseline-risk weighted variances; and Cov cw (x,z) is the analogous covariance between
the exposure and covariate values for individuals within county c.
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